Related Experiment Videos
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.
M V Barone1, L Sepe, R M Melillo
1Centro di Endocrinologia ed Oncologia Sperimentale del CNR, c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli "Federico II", via S. Pansini 5, Naples, Italy.
Oncogene
|November 13, 2001
Summary
Thyroid papillary carcinomas with RET/PTC1 rearrangements induce stress fibers via Rho GTPase activity. This actin reorganization is specific to thyroid cells and linked to cell survival.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Thyroid papillary carcinomas often feature RET/PTC rearrangements, leading to constitutively active RET kinase.
- The RET/PTC1 oncogene's role in cellular actin organization is not fully understood.
Purpose of the Study:
- To investigate the effects of the RET/PTC1 oncogene on actin reorganization in thyroid epithelial cells.
- To determine the specific signaling pathways and cell types involved in RET/PTC1-induced actin changes and their impact on cell survival.
Main Methods:
- Analysis of actin stress fiber formation in PC Cl 3 rat thyroid epithelial cells expressing RET/PTC1.
- Comparison with other oncogenes (Src, Ras, Raf) and RET variants (RET/MEN 2A).
- Assessment of RET/PTC1-induced effects in different cell lines (human thyroid carcinoma, NIH3T3 fibroblasts, MCF7 mammary cells) and the role of Rho and Rac GTPases.
Main Results:
- RET/PTC1 oncogene specifically induced prominent actin stress fibers in thyroid cells, unlike other oncogenes.
- Stress fibers were observed in human thyroid papillary carcinoma cells with RET/PTC1 rearrangements.
- RET/PTC1-mediated stress fiber formation and cell survival were dependent on Rho GTPase activity, but not Rac, and were cell type-specific.
Conclusions:
- The chimeric RET/PTC1 oncogene drives unique actin reorganization and promotes thyroid cell survival through Rho GTPase signaling.
- These findings highlight the cell type- and oncogene-specific roles of Rho in mediating RET/PTC1 effects in thyroid cancer.